GlaxoSmithKline Inc.

Jul 23, 2025

Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma

Jun 06, 2025

GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo School of Pharmacy

Feb 25, 2025

National survey reveals low understanding of shingles risk factors and lack of concern among those at increased risk

Dec 05, 2024

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer

Oct 09, 2024

Data from new national study exposes oral corticosteroids overuse in Canadian patients with severe asthma